Allscripts (MDRX) Reports In-Line Q2 EPS, Offers Guidance, Approves $250M Buyback
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- US futures fall on tech selloff as concerns about hawkish Fed, AI spending mount
- Nasdaq 100 set to shed over $1 trillion as tech selloff deepens; SpaceX slides
- Oil steady as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Trump announces nuclear deal with Iran, lifts Hormuz blockade
- Spain's ex-transport minister sentenced to 24 years for corruption
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
Allscripts announces second quarter 2018 results
August 2, 2018 4:01 PM EDTReported second quarter growth of 23% in GAAP revenue to $526 million, 25% in non-GAAP revenue to $536 millionSecond quarter GAAP EPS of $0.36, growth of 20% in non-GAAP EPS to $0.18Announces new $250 million stock repurchase authorization Closed acquisition of HealthGrid to expand FollowMyHealth® patient engagement platformClosed sale of OneContent; recognized gain of $178 million
CHICAGO, Aug. 02, 2018 (GLOBE NEWSWIRE) -- Allscripts Healthcare Solutions, Inc. (Nasdaq: MDRX) (Allscripts) announced its financial results for the three and six months ended June 30,... More
